Intestinal Na+–K+–ATPase activity and molecular events downstream of interferon‐γ receptor stimulation
Open Access
- 1 August 2004
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 142 (8) , 1281-1292
Abstract
This study evaluated the effects of human interferon‐γ (IFN‐γ) on Na+–K+–ATPase activity and the intracellular signaling pathways involved in human intestinal epithelial Caco‐2 cells. Na+–K+–ATPase activity was determined as the difference between total and ouabain‐sensitive ATPase. p38 MAP kinase activity was analyzed by Western blotting using the p38 MAP kinase assay kit. Total and phosphorylated STAT1 protein levels were detected using the PhosphoPlus® Stat1. IFN‐γ decreased Na+–K+–ATPase activity in a time‐ and concentration‐dependent manner. The IFN‐γ‐induced decrease in Na+–K+–ATPase activity was accompanied by no changes in the abundance of α1 subunit Na+–K+–ATPase. Downregulation of protein kinase C (PKC) with phorbol‐12,13‐dibutyrate (PDBu) prevented the inhibitory effect of IFN‐γ on Na+–K+–ATPase activity. Inhibition of Raf‐1, mitogen‐activated protein kinase kinase (MAPKK/MEK), p38 MAPK and STAT1 with, respectively, GW 5074, PD 98059, SB 203580 and epigallocatechin gallate prevented inhibition of Na+–K+–ATPase activity by IFN‐γ. Treatment with IFN‐γ markedly increased the expression of total and phospho‐STAT1, this being accompanied by activation of p38 MAPK. Activation of phospho‐STAT1 by IFN‐γ was almost abolished by epigallocatechin gallate and markedly reduced by SB 203580, but insensitive to downregulation of PKC. The increase in short circuit current (Isc) by 1.0 and 2.5 μg ml−1 amphotericin B was markedly attenuated in IFN‐γ‐treated cells. However, the inhibitory effect of PDBu on the amphotericin B‐induced increase in Isc was of similar magnitude in vehicle‐ and IFN‐γ‐treated cells. It is concluded that IFN‐γ markedly attenuates Na+–K+–ATPase activity. The transduction mechanisms set into motion by IFN‐γ involve the activation of PKC downstream STAT1 phosphorylation and Raf‐1, MEK, ERK2 and p38 MAPK pathways, in a complex sequence of events. British Journal of Pharmacology (2004) 142, 1281–1292. doi:10.1038/sj.bjp.0705895Keywords
This publication has 56 references indexed in Scilit:
- Evidence for the critical role of interleukin‐12 but not interferon‐γ in the pathogenesis of experimental colitis in miceJournal of Gastroenterology and Hepatology, 2003
- Interferon-γ-induced Epithelial ICAM-1 Expression and Monocyte AdhesionJournal of Biological Chemistry, 2002
- Low Levels of IFN-γ Down-regulate the Integrin-dependent Adhesion of B Cells by Activating a Pathway That Interferes with Cytoskeleton RearrangementJournal of Biological Chemistry, 2001
- Comparative study on sodium transport and Na+,K+-ATPase activity in Caco-2 and rat jejunal epithelial cells: Effects of dopamineLife Sciences, 2001
- Anti‐interferon‐γ action of epigallocatechin‐3‐gallate mediated by specific inhibition of STAT1 activationThe FASEB Journal, 2001
- Activation of Raf-1 by Interferon γ and Oncostatin M Requires Expression of the Stat1 Transcription FactorJournal of Biological Chemistry, 1998
- Protein kinase C-ε associates with the Raf-1 kinase and induces the production of growth factors that stimulate Raf-1 activityOncogene, 1997
- Antibodies to interleukin 12 abrogate established experimental colitis in mice.Journal of Experimental Medicine, 1995
- Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR)Clinical and Experimental Immunology, 1995
- Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers.Journal of Clinical Investigation, 1989